3649 results for «480»

Filter By

3649 results

GulfPCR-GIM 2017 Opening Ceremony

13 Dec 2017 – From GulfPCR-GIM 2017

Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...

GulfPCR-GIM 2017 Opening Ceremony

GulfPCR-GIM 2017 Award and Closing Ceremony

14 Dec 2017 – From GulfPCR-GIM 2017

Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.

GulfPCR-GIM 2017: Award and Closing Ceremony

PCR Tokyo Valves 2018: Opening ceremony

31 Mar 2018 – From PCR Tokyo Valves 2018

Consult this session of the PCR Tokyo Valves 2018 opening ceremony and discover a continuum of educational projects in interventional cardiology.

PCR Tokyo Valves 2018: Closing ceremony and Awards

01 Apr 2018 – From PCR Tokyo Valves 2018

Consult this session of the PCR Tokyo Valves 2018 Closing ceremony and find out who the Best abstract winners are.

PCR Tokyo Valves 2018: Closing ceremony and Awards

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease

02 Nov 2022

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working
Didn’t find what you were looking for?